ReproCELL Incorporated

¥106.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4978Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (13.66%)
Div yield —
ROE (4.92%)
Biotechnology
Beta (5Y) 0.58
PE TTM —
TSR TTM (40.11%)
Mkt cap ¥11.32B
ROIC (6.20%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥102
(3.75%)
(78.87%)
Buy 4|1|1|9|1
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
1.72
1.74
1.72
1.71
10.68%
5.67%
(1.02%)
(0.65%)
Revenue¥M
594.2
610.5
607.5
620.0
6.71%
7.41%
3.82%
1.94%
Peers (US$71.85M)
Cap (US$)
PE
83.60M
—
64.32M
—
71.86M
—
Capital
TTM
5Y
10Y
Leveragex
1.041
(0.013)
(0.012)
EBIT/Intx
3.498
0.106
0.107
Own earn%
6.97
(371.02)
(295.24)
Sh yield%
23.36
36.53
39.37
Owners
Insiders/Inst%
6.05
27.12
Short interest%
4.59
SBC / revenue%
5.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
13–23
$1 testx
0.2
Incr. ROIC%
5